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Summary 
What are the new findings? 
• Contrary to expectation, those with patellofemoral pain and greater foot pronation 
(measured as midfoot width mobility) did not have superior benefits using foot 
orthoses, compared to hip exercises.  
• This randomised clinical trial provides evidence that foot orthoses and hip exercises 
offer similar global outcomes in the management of patellofemoral pain.  
 
Impact on clinical practice 
• These results suggest that clinicians and patients can consider either foot orthoses or 
hip exercises in managing patellofemoral pain. 
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ABSTRACT 
Objectives 
To test (i) if greater foot pronation (measured as midfoot width mobility) is associated with 
better outcomes with foot orthoses treatment, compared to hip exercises, and (ii) if hip 
exercises are superior to foot orthoses, irrespective of midfoot width mobility. 
 
Methods 
A two-arm parallel, randomised superiority clinical trial was conducted in Australia and 
Denmark. Participants (18-40years) were included who reported an insidious onset of knee 
pain (≥6 weeks duration); ≥3/10 numerical pain rating, that was aggravated by activities (e.g. 
stairs, squatting, running). Participants were stratified by midfoot width mobility (high ≥11mm 
change in midfoot width) and site, randomised to foot orthoses or hip exercises and blinded 
to objectives and stratification. Success was defined a-priori as much better or better on a 
patient-perceived 7-point scale at 12 weeks. 
 
Results  
Of 218 stratified and randomised participants, 192 completed 12week follow-up. This study 
found no difference in success rates between foot orthoses versus hip exercises in those 
with high (6/21 v 9/20; 29% v 45% respectively) or low (42/79 v 37/72; 53% v 51%) midfoot 
width mobility. There was no association between midfoot width mobility and treatment 
outcome (Interaction effect P=0.19). This study found no difference in success rate between 
foot orthoses versus hip exercises (48/100 v 46/92; 48% v 50%). 
 
Conclusion 
Midfoot width mobility should not be used to help clinicians decide which patient with 
patellofemoral pain might benefit most from foot orthoses. Clinicians and patients may 
consider either foot orthoses or hip exercises in managing patellofemoral pain.  
 
Word count: 247 
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https://www.anzctr.org.au/Trial/Registration/TrialReview/FOHX_trial 
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INTRODUCTION  
Persistent pain affects approximately 126 million people in the United States, costs over 
$560 billion annually and severely affects the quality of life of the individual [1, 2]. One such 
recalcitrant pain condition is patellofemoral pain (PFP). The prevalence of PFP is between 23 
and 29% in the general and adolescent populations [3]. It is associated with a high risk of 
long-term pain, as one in two will continue to suffer after 5-8 years [4]. Radiographic and 
magnetic resonance imaging evidence suggests PFP could be one of the earliest 
manifestations of patellofemoral joint osteoarthritis [5]. The aetiology of PFP remains 
unknown, but is considered multifactorial with a combination of underlying biomechanical, 
neuromuscular and/or psychological contributors [6-8]. Patellofemoral pain is a clinical 
diagnosis based on a typical presentation of pain around or behind the patella during daily 
activities such as negotiating stairs, squatting or sitting [9].  
 
Systematic reviews [10, 11] and international consensus [12] recommend foot orthoses [13, 
14] and especially a focus on hip exercises [15, 16] in the management of PFP. The 
quandary is how to best tailor the most efficacious treatment to the individual’s presentation 
and characteristics to ensure optimal outcomes. [17] Evidence suggests that greater mobility 
of the midfoot (defined as a change of 11mm or more in midfoot width when moving from 
non-weight bearing to weight bearing [18]), is associated with better outcomes following foot 
orthoses [19, 20]. Crucially, methodological considerations in previous literature, such as lack 
of a comparator treatment and potential over-fitting of models for outcomes, may have 
created spurious findings, compromising their clinical applicability [10, 21]. Further 
investigation is needed to examine if a simple clinical measurement of the foot [18] can be 
used to determine which patient will benefit the most from which treatment (i.e. foot orthoses 
versus another comparable treatment for PFP; i.e., hip exercises).  
 
The aims of this trial were to: (i) evaluate if greater midfoot width mobility is associated with a 
better outcome following treatment with foot orthoses when compared to hip exercises, and 
(ii) compare the treatment effectiveness of foot orthoses relative to hip exercises at 12 
weeks, irrespective of midfoot mobility, in the management those with PFP. The hypotheses 
were that (i) those with greater midfoot width mobility will have greater benefit with foot 
orthoses, compared to hip exercises, and (ii) those that receive hip exercises will report 
greater overall benefits than those who receive foot orthoses. 
 
METHODS 
Study Design 
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A two-arm parallel, multi-centre randomised superiority clinical trial was conducted in a 
community setting in Brisbane, Australia, and hospital outpatient department in Aalborg, 
Denmark. The trial was prospectively registered (ACTRN12614000260628) and the protocol 
published elsewhere [22]. The trial adhered to the principles of the Declaration of Helsinki 
[23] with ethical approval granted by the University of Queensland Medical Research Ethics 
Committee (2013000981) and the ethics committee in the North Denmark Region (N-
20140022). The trial was conducted in agreement with the registration and more specifically 
the published protocol [22], with the exception that the patient specific functional scale and 
international physical activity questionnaire were not analyzed due to reporting errors. The 
reporting of this clinical trial follows the CONSORT statement and TIDieR for describing 
interventions [24-26]. 
 
Participants  
Volunteers from Brisbane, Australia and Aalborg, Denmark responded to advertisements or 
were referred by health care practitioners. Inclusion criteria were: age 18-40 years; insidious 
onset of anterior, retro or peri-patellar pain aggravated by at least two activities (e.g. stair 
ambulation, squatting, jogging/running); reported pain of at least 3 out of 10 on a numerical 
pain rating scale (10 representing worst pain imaginable) over the last 7 days; greater than 
six weeks’ duration and tenderness on palpation of the patellar borders with reproduction of 
pain completing a step down or double leg squat. Participants were excluded if they reported 
traumatic onset of symptoms; concomitant injuries or pain from the hip, lumbar spine, or 
other knee structures that manifested with similar symptoms; patellar dislocation or 
instability; previous knee surgery; evidence of knee joint effusion; any foot condition that 
precluded use of foot orthoses; the use of anti-inflammatory drugs or corticosteroid 
medication; or previous treatment for PFP that included foot orthoses or hip exercises. 
Eligible participants were required to have comprehension of written and spoken English 
(Brisbane, Australia) or Danish (Aalborg, Denmark). 
 
Stratification  
Midfoot width mobility at baseline was defined as the difference between non-weight bearing 
and weight bearing measurements of the width of the participant’s midfoot (defined as 50% 
of total foot length) [18]. This measurement is highly reliable (inter-rater ICC(2,1) >0.83, intra-
rater ICC(2,1) >0.97), with standard error of the measure being less than 0.19mm [18]. 
Stratification occurred using a pre-determined cutoff for midfoot width mobility of 11mm [19, 
20]; those who presented with equal to, or greater than 11mm midfoot width mobility were 
defined as ‘high mobility’ and those with less than 11mm as ‘low mobility’ [22].  
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Randomisation and blinding 
An independent off-site body generated a randomisation schedule by computer for all 
participants at both the Australian and Danish sites before trial initiation. They were sent to 
the two study sites and kept in a locked cabinet.  Allocation to each treatment via sealed and 
opaque envelopes was done in a 1:1 ratio using random permuted blocks of sizes 8 to 
16; with stratification by midfoot width mobility and site (Brisbane or Aalborg). A researcher 
determined eligibility and collected all baseline measurements, except midfoot width mobility 
status. A separate researcher, blind to all baseline information, measured each participant’s 
midfoot width prior to allocation to one of the treatments. Randomisation occurred once 
participants were stratified on midfoot width mobility. A separate researcher communicated 
with the randomisation centre, trial participants, and physiotherapists and sites. The outcome 
assessor was blind to treatment allocation and midfoot width mobility status. Physiotherapists 
were kept blind to the participant’s stratification and study hypothesis. Participants were 
informed the study involved two evidence-based treatments (foot orthoses or hip exercises), 
but were kept blind to midfoot width mobility status and study hypothesis. 
 
Interventions  
Registered physiotherapists completed three pre-trial familiarisation sessions prior to 
applying both interventions [22]. The first session covered trial details and foot orthoses 
prescription, the second to practice the hip exercise program, and the third was for 
checking/revising content from the previous sessions. Prescription of foot orthoses followed 
the protocol utilised in a previous randomised clinical trial [13]. The hip exercises targeting 
posterior-lateral hip muscles are reproduced from a previous randomised clinical trial in those 
with PFP [15], with their efficacy supported in clinical trials [15, 16]. Fees and costs for the 
interventions, including materials, were covered by the project. 
 
Foot orthoses 
Physiotherapists fitted commercially available prefabricated foot orthoses (Vionics 
International, Australia) and a pair of orthosis-like contoured sandals [27]. Physiotherapists 
followed a standardised fitting process that prioritised comfort [28], with scope to review size, 
length and hardness [22]. Participants performed a home exercise program twice per day, 
consisting of calf stretches and anti-pronation foot exercises, aimed to improve foot 
awareness, with full details previously published [22]. Participants attended six sessions over 
six weeks to fit and revise orthoses and ensure home exercise fidelity. No instructions were 
given with regards to continuing or discontinuing foot orthoses after the six sessions. 
 
Hip exercises  
 7 
The hip exercise protocol followed recommended prescribing guidelines [29]. Full details of 
the exercise protocol are previously published [22]. Progressive, resisted hip exercises were 
performed bilaterally and focused on the hip abductor, external rotator, and hip extensor 
muscle groups in side lying, supine and standing. Participants attended a physiotherapist-
supervised one-on-one exercise session, three times per week for four weeks (12 sessions 
total). Physiotherapists selected predetermined lengths and grade of elasticated band at 
each session, which provided sufficient resistance for participants to achieve a maximum of 
10 repetitions and perceived exertion of 5 to 7/10 (Hard to Very hard) per exercise. No 
instructions were given with regards to continuing or discontinuing hip exercises after the 12 
sessions.  
 
Primary outcome 
The primary outcome measure was a 7-point Likert global rating of change (GROC) scale 
with categories of much better, better, a little better, no change, a little worse, worse or much 
worse. This measure has been previously utilised in similar trials on PFP [13, 30]. A 
successful outcome was a-priori defined as being much better or better at the primary time 
point of interest at 12 weeks. 
 
Secondary outcomes  
Secondary participant rated outcomes included the single assessment numeric evaluation 
(SANE) to rate the normality of their knee and their recovery out of 100% (100% being 
defined as having no problems at all and fully recovered), patient acceptable symptom state 
(PASS) by answering if their current condition was satisfactory, taking into consideration their 
general functioning and current pain (yes/no), perception of success by answering if they 
agreed their treatment was successful (yes/no), Kujala anterior knee pain scale, knee injury 
and osteoarthritis outcome scale (KOOS), numerical rating of pain severity over the last 
seven days, hospital anxiety and depression scale, Euro-Qol™ (EQ-5D), kinesiophobia, and 
pain catastrophising [22]. Physical performance tests included hip strength measures and 
number of pain-free (i) step ups, (ii) step downs (25cm step), and (iii) squats to a metronome 
set to 96 beats per minute [22]. 
 
Statistical analysis 
Sample size calculations were based on proportions of patients in each group rating 
themselves as “much better” or “better” on the GROC score. The primary aim was to detect 
an interaction effect of 50 percentage points between midfoot mobility stratum and treatment 
group. This would mean that a treatment effect favoring foot orthoses (the difference 
between the foot orthoses and hip exercise groups in the proportions of participants who had 
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successful outcomes at 12 weeks) was 50 percentage points higher in participants with high 
mobility than in those with low mobility. Assuming that: (i) in participants with high mobility, 
80% would have successful outcomes with foot orthoses compared to 30% with hip 
exercises, (ii) 20% of participants would have high mobility (based on previous data [20]), 
and (iii) loss to follow-up would be up to 15%, 220 participants (110 per group) were required 
to have 80% power to detect the aforementioned interaction effect using a two-sided 
significance level of 0.05 [22, 31].  
 
A statistical analysis plan was published prior to analysis and is available on request 
(https://espace.library.uq.edu.au/view/UQ:623536). A biostatistician blinded to group 
allocation conducted all analyses. All analysis of data was conducted on an intention-to-treat 
basis including all randomised participants. Characteristics of treatment groups were 
summarised as mean (standard deviation) for continuous variables and as count 
(percentage) for categorical variables. Data were analysed on an intention to treat basis 
using Stata v14.1 (StataCorp), including all randomised participants in their assigned group. 
Missing baseline variables were imputed using single mean imputation [32]. Estimates from 
20 imputed datasets were combined using Rubin’s rules [33]. Datasets were imputed using 
chained equations, with predictive mean matching from the three nearest neighbours for 
continuous outcomes and logistic regression for binary outcomes. Imputation was done 
separately for each treatment arm, including a range of variables in the imputation models. 
For dichotomous outcomes, binary regression models with a logarithmic link were fitted using 
generalised estimating equations with an exchangeable working correlation matrix to account 
for the two follow-up measurements per participant (at 6 and 12 weeks). That is, baseline 
measures were not included as outcomes in the models. Models included a three-way 
interaction between treatment group, midfoot mobility stratum, and follow-up visit number (1 
or 2), all two-way interactions, main effects, and a term for country (Australia or Denmark). 
The relative risk (RR) comparing treatment groups in each midfoot mobility by time stratum 
was calculated with 95% confidence intervals. To compare outcomes between treatment 
groups, similar models including only a main effect for midfoot mobility were fitted. Similar 
models for continuous outcomes were fitted, again using generalised estimating equations, 
additionally including a term for the baseline level of the outcome.  
 
Patient involvement 
Patient representatives were engaged in the development stages of the study. Prior to 
providing consent, all participants were informed of the study requirements, asked if they 
were willing to undergo their allocated intervention, and informed they will be emailed the 
final results. 
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RESULTS 
Participants 
Between June 2014 to April 2017, 220 participants enrolled in the study. Two non-
randomised cases were erroneously included and were removed when identified as such 
after close out, resulting in 218 participants (138 in Australia, 80 in Denmark). Forty-nine 
(22%) participants were classified as high mobility and 169 (78%) as low mobility (Figure 1). 
Treatment groups and treatment-by-mobility groups were well matched at baseline (Table 1). 
One participant in the low mobility foot orthoses group received hip exercises incorrectly. 
Participants who did not provide a GROC score were deemed to have been lost to follow-up. 
There were 197 (90%) participants followed up at 6 weeks and 192 (88%) at 12 weeks.  
 
Figure 1: CONSORT Flow of participants through the study 
 
Table 1: Baseline characteristics of participants for intervention and stratified groups.   
 
Foot 
Mobility 
Strata Total 
Hip 
Exercises Foot Orthoses 
Site     
Both (n (%)) High 49 (22.5) 25 (22.9) 24 (22.0) 
 Low 169 (77.5) 84 (77.1) 85 (78.0) 
 All 218 109 109 
     
Australia (n (%)) High  28 (12.8) 14 (12.8) 14 (12.8) 
 Low  110 (50.1) 55 (50.1) 55 (50.1) 
 All 138 (63.3) 69  (63.3) 69 (63.3) 
           
Denmark (n (%)) High 21 (9.6) 11 (10.1) 10 (9.2) 
 Low 59  (27.1) 29 (26.6) 30 (27.5) 
 All 80 (36.7) 40 (36.7) 40 (36.7) 
     
Sex High  32 (65.3) 16 (64.0) 16 (66.7) 
Female (n (%)) Low 119 (70.4) 54 (64.3) 65 (76.5) 
 All 151 (69.3) 70 (64.2) 81 (74.3) 
     
Bilateral symptoms High 37 (78.7) 17 (73.9) 20 (83.3) 
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Yes (n (%)) Low 109 (66.1) 52 (63.4) 57 (68.7) 
 All 146 (68.9) 69 (65.7) 77 (72.0) 
     
Study Knee (most 
problematic) High  30 (63.8) 16 (69.6) 14 (58.3) 
Right (n (%)) Low  81 (49.4) 43 (52.4) 38 (46.3) 
 All 111 (52.6) 59 (56.2) 52 (49.1) 
 
    
Age (years mean (SD)) High  27.8 (5.8) 29.2 (4.9) 26.4 (6.3) 
 
Low 28.2 (6.1) 28.0 (6.3) 28.3 (5.9) 
 All 28.1 (6.0) 28.3 (6.0) 27.9 (6.0) 
 
    
Height (cm mean (SD)) High  170.0 (10.5) 169.1 (10.1) 170.9 (11.1) 
 
Low 171.5 (9.3) 172.1 (9.7) 171.0 (8.9) 
 All 171.2 (9.6) 171.4 (9.8) 171.0 (9.4) 
 
    
Weight (kg mean (SD)) High  76.0 (14.9) 80.7 (15.5) 71.0 (12.7) 
 
Low  73.3 (17.0) 73.7 (17.0) 72.9 (17.1) 
 All 73.9 (16.5) 75.3 (16.9) 72.5 (16.2) 
     
BMI (kg/m2 mean (SD)) High  26.3 (4.8) 28.3 (5.3) 24.3 (3.4) 
 
Low  24.8 (4.8) 24.7 (4.5) 24.9 (5.1) 
 All 25.1 (4.8) 25.5 (4.9) 24.7 (4.8) 
 
    
Duration of Symptoms  High  62.6 (69.0) 67.6 (67.0) 57.7 (72.1) 
(months mean (SD)) Low  51.3 (58.8) 47.9 (60.1) 54.8 (57.7) 
 All 53.8 (61.2) 52.3 (61.9) 55.4 (60.8) 
 
    
Self-reported measures     
     
Worst Pain  High  6.4 (2.0) 6.4 (2.4) 6.2 (1.9) 
(NRS mean (SD)) Low  6.25 (2.0) 6.2 (2.0) 6.1 (2.3) 
 All 6.3 (2.0) 6.3 (2.0) 6.3 (2.0) 
     
Tampa High  39.3 (6.7) 39.3 (6.5) 39.2 (7.0) 
(mean (SD)) Low  39.5 (5.5) 38.9 (5.4) 40.0 (5.5) 
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 All 39.4 (5.7) 39.0 (5.6) 39.9 (5.8) 
     
HADS Anxiety High  6.4 (3.1) 6.2 (3.1) 6.2 (3.4) 
(mean (SD)) Low  5.8 (3.9) 5.6 (3.8) 6.0 (3.9) 
 All 5.9 (3.7) 5.8 (3.6) 6.0 (3.8) 
     
HADS Depression High  2.9 (2.5) 3.0 (2.7) 2.8 (2.2) 
(mean (SD)) Low  3.0 (2.6) 3.0 (2.7) 3.0 (2.6) 
 All 3.0 (2.6) 3.0 (2.7) 3.0 (2.5) 
     
Pain Catastrophising Scale High  13.4 (8.3) 12.6 (7.5) 13.7 (9.5) 
(mean (SD)) Low  12.5 (9.5) 11.9 (8.5) 13.0 (10.5) 
 All 12.7 (9.3) 12.2 (8.2) 13.3 (10.2) 
     
Percentage of normal  High  59.7 (19.1) 54.0 (25.5) 55.6 (24.2) 
(0-100% mean (SD)) Low  59.6 (21.5) 55.8 (25.8) 52.1 (28.0) 
 All 59.6 (20.9) 60.3 (20.3) 58.8 (21.6) 
     
KOOS (mean (SD)) High  65.6 (16.0) 66.1 (15.8) 65.2 (16.4) 
 Symptoms Low  68.1 (15.3) 69.3 (16.2) 66.9 (14.4) 
  All 67.6 (15.4) 68.6 (16.1) 66.5 (14.8) 
     
Pain High  69.1 (12.1) 67.2 (12.4) 70.9 (11.7) 
 Low  69.0 (12.9) 69.5 (13.0) 68.5 (12.9) 
 All 69.0 (12.7) 69.0 (12.9) 69.0 (12.6) 
     
 Activities of daily living High  78.9 (13.4) 79.4 (14.5) 78.4 (12.5) 
 Low  79.3 (13.0) 79.7 (12.7) 78.9 (13.4) 
  All 79.2 (13.1) 79.6 (13.1) 78.8 (13.1) 
     
Sporting and recreation High  52.5 (22.9) 49.2 (23.4) 55.8 (22.3) 
 Low  52.4 (21.6) 55.5 (20.9) 49.2 (22.0) 
  All 52.2 (21.6) 54.1 (21.5) 50.7 (22.1) 
     
Quality of Life High  48.4 (16.7) 48.4 (13.9) 48.4 (19.4) 
 Low  44.9 (15.8) 45.9 (16.9) 43.9 (14.6) 
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 All 45.7 (16.0) 46.5 (16.3) 44.69 (15.8) 
     
KOOS Patellofemoral High  52.9 (19.1) 51.1 (19.0) 54.9 (19.5) 
(mean (SD)) Low  52.3 (16.1) 52.5 (15.2) 50.0 (17.7) 
 All 52.3 (16.1) 52.2 (16.1) 51.0 (18.1) 
     
Physical measurements     
Functional tests study knee High  13.5 (8.3) 13.6 (8.4) 13.5 (8.4) 
 Step-up (n mean (SD)) Low  13.1 (8.6) 13.1 (8.6) 13.2 (8.6) 
 All 13.2 (8.5) 13.2 (8.5)  13.3 (8.6) 
     
Step-down (n mean (SD)) High  8.7 (8.5) 8.4 (8.6) 9.0 (8.6) 
 Low  7.7 (7.5) 7.5 (7.3) 8.0 (7.7) 
 All 7.9 (7.7) 7.7 (7.6) 8.2 (7.9) 
     
Squats (n mean (SD)) High  9.9 (7.3) 10.7 (7.5) 9.0 (7.1) 
 Low  9.2 (7.7) 8.5 (7.5) 9.9 (7.9) 
 All 9.4 (7.6) 9.0 (7.5) 9.7 (7.7) 
     
Beighton Joint Mobility  High  2.3 (2.3)  1.9 (2.4) 2.6 (2.3) 
(mean (SD)) Low  2.2 (2.3) 1.9 (2.3) 2.4 (2.2) 
 All 2.2 (2.3) 1.9 (2.3) 2.5 (2.2) 
     
Hip Strength study knee  High  1.39 (0.33) 1.35 (0.29) 1.44 (0.38) 
 Abduction  Low  1.43 (0.41) 1.47 (0.42) 1.39 (0.39) 
(Nmkg-1 mean (SD)) All 1.42 (0.39) 1.44 (0.40) 1.40 (0.39) 
     
Adduction  High  1.45 (0.40) 1.44 (0.43) 1.46 (0.37) 
(Nmkg-1 mean (SD)) Low  1.43 (0.47) 1.49 (0.49) 1.38 (0.44) 
 All 1.44 (0.45) 1.48 (0.48) 1.40 (0.43) 
     
External rotation  High  0.48 (0.12) 0.49 (0.13) 0.47 (0.11) 
(Nmkg-1 mean (SD)) Low  0.45 (0.12) 0.46 (0.12) 0.44 (0.13) 
 All 0.46 (0.12) 0.46 (0.12) 0.45 (0.12) 
     
Hip ROM study knee High  25.3 (7.6) 23.4 (8.4) 26.2 (8.3) 
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 Internal rotation  Low  26.9 (8.0) 26.5 (7.6) 27.3 (8.3) 
    (degrees mean (SD)) All 26.5 (7.9) 26.0 (7.5) 27.0 (8.3) 
     
External rotation High  32.8 (7.7) 32.0 (9.8) 32.2 (8.2) 
   (degrees mean (SD)) Low  32.8 (7.4) 33.1 (8.0) 32.5 (6.8) 
 All 32.7 (7.4) 33.1 (7.8) 32.4 (7.1) 
     
Midfoot width Mobility 
study side High  12.6 (1.5) 12.7 (1.4) 12.5 (1.7) 
(mean (SD)) Low  7.4 (2.3) 7.9 (2.0) 6.9 (2.6) 
 All 8.5 (3.1) 9.0 (2.7) 8.1 (3.4) 
     
Foot Posture Index study 
side High  6.0 (4.0) 6.0 (4.6) 5.8 (3.5) 
(mean (SD)) Low  3.3 (4.0) 3.6 (3.9) 2.9 (4.1) 
 All 3.9 (4.2) 4.2 (4.2) 3.6 (4.2) 
     
Navicular Drop study side High  8.3 (4.3) 8.4 (4.9) 8.0 (3.8) 
(mm mean (SD)) Low  5.5 (3.8) 5.6 (3.5) 5.3 (4.1) 
 All 6.1 (4.1) 6.3 (4.0) 5.9 (4.1) 
     
Ankle Dorsiflexion study 
side High  126.0 (35.9) 116.2 (32.3) 135.8 (37.4) 
 Bent knee Low  118.1 (33.4) 112.1 121.4 (31.0) 
    (mm mean (SD)) All 119.9 (34.1) 115.2 (34.7) 124.6 (32.9) 
     
Straight knee High  36.9 (5.4) 35.0 (5.1) 38.7 (5.2) 
   (degrees mean (SD)) Low  37.0 (5.5) 36.2 (5.8) 37.9 (5.1) 
 All 37.0 (5.5) 35.9 (5.7) 38.1 (5.1) 
     
BMI = body mass index; NRS = Numerical rating scale 
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Adherence: 1 
Ten participants did not attend their allocated treatment (n=3 foot orthoses, n=7 hip 2 
exercises). Participants allocated to foot orthoses attended on average 5.5/6 (92%, (1-6)) of 3 
the sessions and reported to have worn their foot orthoses for 74% of waking hours. 4 
Participants allocated to hip exercises attended on average 10.1/12 (84%, (1-12)) of their 5 
sessions.  6 
 7 
Effect of midfoot width on success rates 8 
There was no difference in success rates following foot orthoses or hip exercises in either the 9 
high (29% v 45% respectively) or low midfoot mobility (53% v 51% respectively) strata at 12 10 
weeks (interaction P=0.19) (Fig 2, Table 2). A secondary analysis including midfoot width 11 
mobility as a continuous interval measure showed similar results (P-value 0.66, Appendix 12 
eTable 1). There was no evidence of any significant interactions between treatments and 13 
midfoot mobility strata in any of the secondary outcome measures (Appendix eTable 2).  14 
 15 
 15 
 16 
Figure 2: Percentage and number of participants rating perceived global change across categories from much better to much worse 17 
 18 
 19 
Table 2: Treatment outcomes for foot orthoses versus hip exercises at 12 weeks, grouped according to midfoot width mobility stratification 20 
 21 
Midfoot Width 
Mobility 
Hip Exercises  
(successful+/total (%))* 
Foot orthoses  
(successful+/total (%))* 
Foot orthoses vs Hip exercises^ 
Relative Risk (95% CI) P-value 
High (≥11 
mm) 
9/20 (45.00) 6/21 (28.57) 0.58 (0.26, 1.32) 0.20 
Low (<11 mm) 37/72 (51.39) 42/79 (53.16) 1.02 (0.76, 1.36) 0.91 
All 46/92 (50.00) 48/100 (48.00) 0.94 (0.72, 1.24) 0.67 
+ successful defined as much better or better on GROC, * frequency counts are complete-cases, ^ point estimates (Relative Risk) are based on 22 
multiply imputed data  23 
 16 
Foot orthoses versus hip exercises   24 
There was no difference in success rates patients randomised to foot orthoses (48%) relative 25 
to hip exercises (50%) (RR 0.94, 95% CI (0.72 to 1.24) Table 2). Although there appeared to 26 
be small p-values favoring hip exercises versus foot orthoses at 12 weeks on three KOOS 27 
subscales (symptoms (75.8 vs. 71.7, coefficient -2.92 (-5.52 to -0.32), p=0.028), pain (80.7 28 
vs. 76.4, coefficient -4.09 (-7.63 to -0.55), p=0.023) and daily living (88.6 vs. 84.9, coefficient 29 
-3.37 (-6.54 to -0.20), p=0.037)), the clinical significance of these findings are questionable. 30 
There was no evidence of any differences between groups with respect to the other 22 31 
secondary outcome measures (Appendix eTable2) 32 
 33 
Co-interventions 34 
Two participants reported undertaking additional treatments. One participant from the low 35 
mobility-foot orthoses group commenced yoga between the 6 and 12-week follow-up 36 
sessions, and another used knee wraps while exercising with heavy weights.  37 
 38 
Adverse events  39 
Fourteen participants allocated to foot orthoses (14/109, 13%) reported temporary toe and/or 40 
foot discomfort (n=7) or rubbing/ blistering (n=7) of the skin. Five participants allocated to hip 41 
exercises (5/109, 5%) reported increased discomfort in the hip region after exercises. No 42 
adverse events prevented participants from continuing treatment.   43 
 44 
DISCUSSION:  45 
There was no moderating effect of foot mobility on treatment effects 46 
The results do not support the hypothesis that greater midfoot width mobility, as a cut-off 47 
(≥11mm) or as a continuous measurement, as a treatment effect modifier for prescribing foot 48 
orthoses over hip exercises. This conclusion should be tempered by considering the wide 49 
confidence intervals of the interaction effect does not rule out the existence of a potentially 50 
important interaction. There was no evidence to indicate hip exercises or foot orthoses were 51 
more effective than the other in improving PFP outcomes.  52 
 53 
Previous clinical trials have shown foot orthoses to be effective compared to a wait-and-see 54 
or flat inserts [13, 20]. Theoretical and preliminary evidence [6, 19, 20] suggested that 55 
individuals with greater foot pronation (measured as midfoot width mobility) would benefit 56 
most from foot orthoses intervention. Our study contradicts these preliminary findings and 57 
suggests midfoot mobility should not be the primary deciding factor in prescribing foot 58 
orthoses.  59 
 60 
 17 
There was no difference between foot orthoses and hip exercise: is this because there was 61 
no change over time (baseline to 12 weeks) in both groups? 62 
Our finding that there was no strong evidence of an interaction or treatment effects could 63 
stem from there being no change over time in both treatments. When we compare the 64 
change over time of foot orthoses using a similar outcome (i.e. global rating of change), the 65 
changes we observed were similar to others (48% vs 47% [20]). Likewise, when we use 66 
similar outcomes for exercise programs that included hip exercises (i.e. change in self-67 
reported pain and/or anterior knee pain scales), we see similar changes (71% vs 80% [16]). 68 
Overall the changes over time in the foot orthoses or hip exercise groups is similar across a 69 
number of studies and various self-reported outcome measures, [16, 20, 30] which increases 70 
our confidence that our treatments were similar to other trials. 71 
 72 
 73 
Is four weeks of exercise sufficient?  74 
Whilst our study did not compare different durations of exercise interventions, the response 75 
to four weeks of exercise was sufficient to induced comparable strength changes and 76 
success rates to previous trials [16]. Exercise therapy is recommended for those with PFP 77 
[12] but exercise protocols vary between trials, [15, 16] and generally lack specific exercise 78 
descriptors [29]. A study with the highest success rates (80%) after six weeks of hip and core 79 
exercises [16], reported a notable increase in hip external rotator and abductor muscle 80 
strength (8% and 11% increases respectively). Their six-week exercise protocol consisted of 81 
a supervised and home-based program (6 days/week) that targeted hip abductor, extensor, 82 
internal and external rotator muscle groups (three-sets of 10 repetitions), and a balance air-83 
pad exercise (three-sets of 30-60seconds). We observed a similar success rate (71%) and 84 
change in muscle strength of the same muscle groups, 11% and 6% respectively, with our 85 
four-week physiotherapist-supervised program (3 days/week). The exercises targeted the hip 86 
abductor, external rotator and extensor muscles, performed at a hard to very hard perceived 87 
level of exertion with each repetition having a five second time-under-tension cycle. 88 
Adherence was high (84%). We noted that hip strength improvements were maintained 89 
between week 6 and 12, despite the cessation of exercises after four weeks (appendices – 90 
eTables 2). Despite some differences in exercise parameters between studies, there were 91 
comparable success rates and increases in muscle strength suggesting improvements can 92 
be gained by doing simple exercises. 93 
 94 
Limitations  95 
Several limitations need to be considered when inferring from our results. First is the 96 
imbalance in the number of sessions between the hip exercise group (12) and the foot 97 
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orthoses groups (6). Whilst regular visits to the clinician would assure adherence and fidelity 98 
to the treatment, this would plausibly be more resource intensive. Resource requirements 99 
(e,g., costs, training) and possible implications due to the imbalance in treatment sessions 100 
between groups was not collected. Second, clinicians delivered both interventions and may 101 
have conveyed a preference of one over the other to a patient, thereby biasing outcomes. 102 
Third is the use of only one form of prefabricated foot orthoses, and while it was previously 103 
shown to be effective, this might well be a limitation. Other foot orthoses may be more or less 104 
effective and their outcome predictable from basic foot measures. Fourth, those allocated to 105 
foot orthoses were instructed to undertake foot exercises at home, and as such we are 106 
unable to determine if the foot exercises, orthoses, or both were the active components in 107 
the foot orthoses group. Fifth, the four week exercise duration might not be considered a 108 
sufficiently long enough period of exercise, this limitation seems somewhat mitigated 109 
because changes over the 12 weeks in the exercise group in our study was comparable to 110 
those in studies of longer duration exercise [16]. Sixth, based on previous evidence [34], it is 111 
possible there was a subgroup of those with PFP who did not have hip muscle weakness, or 112 
foot mobility issues, but were allocated to hip exercises or foot orthoses respectively. This 113 
would only be a valid concern if the notion that hip muscle weakness or mobility are 114 
treatment effect modifiers, the latter we showed not to be the case. Seventh, sample size 115 
calculations were based on one follow-up visit per participant, however, in our analyses we 116 
analysed both outcomes for each participant simultaneously using generalised estimating 117 
equations. Our sample size calculations thus did not account for multiple measurements per 118 
participant: doing so would have reduced the required number of participants. Eighth, due to 119 
the presence of nonadherence to assigned treatments, the estimated effects in this study 120 
must be interpreted as estimating the effect of assignment to either foot orthoses or hip 121 
exercises, rather than the effect of actually engaging with the assigned treatments [35, 36]. 122 
 123 
Clinical implications  124 
In the management of individuals with PFP, we found that hip exercises or foot orthoses are 125 
equally effective treatments. We feel confident that either treatment is better than no 126 
treatment, because previous studies have shown foot orthoses or thigh exercise to be 127 
superior to wait and see or usual care [16, 20, 30]. In the absence of any differences 128 
between those with greater midfoot width mobility and between the treatments, other 129 
determinants ought to be considered in clinical decisions when managing PFP. For example, 130 
patient preference, resource requirements, and time required for each intervention should 131 
guide treatment selection.  132 
 133 
CONCLUSION 134 
 19 
Greater midfoot width mobility was not associated with greater patient-perceived 135 
improvement with foot orthoses versus hip exercises. Both hip exercises and foot orthoses 136 
offer similar outcomes in reducing pain and improving function. 137 
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